Request for Information (RFI) - 59MDW_DE_RD.docx

THIS IS A REQUEST FOR INFORMATION (RFI)/SOURCES SOUGHT (SS) NOTIFICIATION TO INCLUDE INDUSTRY FEEDBACK

RFI Number: HT9426-26-R-JBC001

1. Title: Research and Development Services for Research Study titled “Mechanisms of RF Interaction with Biological Systems.”

2. Contracting Office: Defense Health Agency (DHA)

3. Location: The United States Air Force (USAF) 59th Medical Wing, Science and Technology Office located at Joint Base San Antonio – Lackland Air Force Base, Texas.

4. Summary: This RFI/SS is issued solely for information and planning purposes and shall not be construed as a solicitation, restrict the Government as to the ultimate acquisition approach, or serve as an obligation on the part of the DHA. In accordance with FAR 15.201(e), responses to this notice are not offers and cannot be accepted by the Government to form a binding contract. Responders are advised that the United States Government will not pay for any information or administrative costs incurred in response to this RFI. All costs associated with responding to this RFI/SS will be solely at the interested responder’s expense. Not responding to this RFI/SS does not preclude participation in any future Request for Proposal, if any is issued. No evaluation letters and/or results will be issued to Responders responding to this RFI/SS.

The information resulting from this RFI/SS will determine interest and capabilities available in the marketplace; and will assist in developing acquisition strategy.

5. Background/Scope: The USAF 59th Medical Wing, Science and Technology Office has a requirement for research and development services. This research study is titled “Mechanisms of Radiofrequency (RF) Interaction with Biological Systems.”

The 59th Medical Wing is committed to the detection and treatment of directed energy (DE) injury. Their research mission is focused on protecting military personnel in a battlespace where DE systems are fielded for a variety of purposes including anti-material and anti-personnel targets. Directed energy technologies are rapidly advancing and are at the forefront of the next generation of military weaponry. The signs and symptoms (or clinical presentation) of directed energy overexposures are not well understood, but represent a significant DoD capability gap, particularly with reference to the ability to diagnose, treat, or prevent injury to our military personnel from accidental or malicious DE overexposure.

This protocol will examine mechanistic interactions between RF overexposure and biological systems in miniature swine animal models. For each paradigm, researchers will correlate exposures with novel biomarkers and clinically translatable outcomes – outcomes detectable using either existing clinical capabilities or easily integrated into current medical practices.

The main objective of this research study is to use clinical evaluation protocols to characterize the biomedical effects of high-power microwave overexposure in Medical Countermeasures of Directed Energy and Unconventionally Acquired Brain Injuries.

How to Respond:

Please submit a Capability Statement that describes relevant experience, expertise, and capabilities based upon the size and scope of this requirement as outlined in the draft SOO.

Each response should include the following business information and must not be more than five (5) pages in length:

a) Company name, mailing address, e-mail address, telephone, website address (if available), and the name, telephone number, and e-mail address of a point of contact having the authority and knowledge to clarify responses with Government representatives.

b) Name, title, telephone number, and e-mail addresses of individuals who can verify the demonstrated capabilities identified in the responses.

c) Unique Entity ID number, CAGE Code, and company structure (Corporation, LLC, partnership, joint venture, etc.). Companies also must be registered in System for Award Management (SAM, at www.sam.gov) to be considered as potential sources.

d) Any and all Government IDIQ Contracts (e.g., Federal Supply Schedule, OASIS, etc.) you currently hold (to include the vehicle and your contract number) that could be used to fulfill this requirement.

e) Describe your organization's specific and relevant experience and expertise to fulfill this requirement. Experience must be of similar size and scope. Please provide examples or provide references of previously completed deliverables related to this requirement.

f) Provide Information relating to capabilities, novel ideas, industry best practices, industry capabilities to meet the needs of the Government’s requirement as outlined in the Request for Information. Do not regurgitate the objective and tasks, rather, outline company specific capabilities that match the work outlined in the Request for Information in order for the Government to make a fair capabilities determination.

Capability statements will be reviewed for (1) Relevant experience based on the size and scope of the outlined requirement; (2) Company specific capabilities that match the work outlined in the RFI. The formal closing date for this RFI/SS and for the submission of all responses is NLT 22 December 2025 at 12:00PM Eastern Time. All responses shall be submitted electronically using PDF or MS Word formats to the POC, Mr. Brandon Clingan at james.b.clingan.civ@health.mil and Mr. Jeremy McMurry at Jeremy.l.mcmurry.civ@health.mil. The Government will not entertain questions regarding this RFI/SS. All responses received will be considered; however, a determination by the Government not to compete the proposed requirement based upon responses to this notice is solely within the discretion of the Government.